info@synchemia.com | sales@synchemia.com 
9766925136 
Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0142772 |
| CAS No | NA |
| Mol.F. | C14H10Cl2N2O4 |
| Mol.Wt. | 341.14 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142773 |
| CAS No | NA |
| Mol.F. | C21H16Cl2N2O3 |
| Mol.Wt. | 415.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142774 |
| CAS No | NA |
| Mol.F. | C18H18Cl2N2O4 |
| Mol.Wt. | 397.25 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142775 |
| CAS No | NA |
| Mol.F. | C20H18Cl2N2O9 |
| Mol.Wt. | 501.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142776 |
| CAS No | NA |
| Mol.F. | C23H22Cl2N2O9 |
| Mol.Wt. | 541.33 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142777 |
| CAS No | NA |
| Mol.F. | C28H19Cl4N3O5 |
| Mol.Wt. | 619.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142778 |
| CAS No | NA |
| Mol.F. | C26H34Cl2N2O3 |
| Mol.Wt. | 493.47g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142779 |
| CAS No | NA |
| Mol.F. | C24H28Cl2N2O3 |
| Mol.Wt. | 463.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142780 |
| CAS No | NA |
| Mol.F. | C32H42Cl2N2O4 |
| Mol.Wt. | 589.60 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142781 |
| CAS No | NA |
| Mol.F. | C35H50Cl2N2O4 |
| Mol.Wt. | 633.70 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142782 |
| CAS No | NA |
| Mol.F. | C14H9ClN2O3 |
| Mol.Wt. | 288.69 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142783 |
| CAS No | NA |
| Mol.F. | C14H10N2O3 |
| Mol.Wt. | 254.25 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142784 |
| CAS No | NA |
| Mol.F. | C17H18ClN3O2 |
| Mol.Wt. | 331.8 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0142785 |
| CAS No | NA |
| Mol.F. | C17H18ClN3O2 |
| Mol.Wt. | 331.8 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142786 |
| CAS No | NA |
| Mol.F. | C17H19N3O2 |
| Mol.Wt. | 297.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142787 |
| CAS No | 1254360-38-7 |
| Mol.F. | C6H11N3O2 |
| Mol.Wt. | 157.2 g/mol |
| INV STATUS | In Stock |
